Cerus (CERS) Operating Income (2010 - 2026)
Cerus (CERS) reported Operating Income of -$354000.0 for Q1 2026, up 93.95% on a YoY basis from -$182519.6 in Q1 2025, and up 44.77% sequentially from -$641000.0 in Q4 2025.
Cerus (CERS) Operating Income (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Operating Income data on file, last reported at -$354000.0 in Q1 2026.
- For the quarter ending Q1 2026, Operating Income rose 93.95% year-over-year to -$354000.0; the trailing twelve-month figure through Mar 2026 stood at -$3.2 million (up 73.7% YoY), and the FY2025 full-year result was -$8.7 million, up 38.97% from the prior year.
- Operating Income climbed to -$354000.0 in Q1 2026, from -$641000.0 in the prior quarter.
- In the past five years, Operating Income ranged from a high of $1.2 million in Q3 2025 to a low of -$14.1 million in Q1 2023.
- A 5-year average of -$5.1 million and a median of -$5.2 million in 2023 frame the typical range for Operating Income.
- Across the five-year window, Operating Income sank 248.46% in 2024 and surged 228.62% in 2025, its largest moves.
- Tracing CERS's Operating Income over 5 years: stood at -$10.0 million in 2022, then soared by 109.81% to $976000.0 in 2023, then slumped by 248.46% to -$1.4 million in 2024, then soared by 55.76% to -$641000.0 in 2025, then jumped by 44.77% to -$354000.0 in 2026.
- Business Quant data shows CERS's Operating Income at -$354000.0 in Q1 2026, -$641000.0 in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 176.64 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 128.78 Bn | 125.90 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 109.01 Bn | 99.79 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | 477.60 Mn |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn | 515.00 Mn |
| 7 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 255.30 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 282.15 Mn |
| 10 | Cerus | 598.93 Mn | 518.50 Mn | 27.89 Mn | -354,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -354,000.00 |
| Dec 31, 2025 | -641,000.00 |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | -3.42 Mn |
| Mar 31, 2025 | -5.85 Mn |
| Dec 31, 2024 | -1.45 Mn |
| Sep 30, 2024 | -961,000.00 |
| Jun 30, 2024 | -3.84 Mn |
| Mar 31, 2024 | -7.98 Mn |
| Dec 31, 2023 | 976,000.00 |
| Sep 30, 2023 | -5.24 Mn |
| Jun 30, 2023 | -11.64 Mn |
| Mar 31, 2023 | -14.15 Mn |
| Dec 31, 2022 | -9.95 Mn |
| Sep 30, 2022 | -7.45 Mn |
| Jun 30, 2022 | -6.84 Mn |
| Mar 31, 2022 | -9.85 Mn |
| Dec 31, 2021 | -6.96 Mn |
| Sep 30, 2021 | -11.13 Mn |
| Jun 30, 2021 | -14.40 Mn |